As per our research analysis, the size of the Nucleic Acid Labelling Market in the Asia Pacific was valued at USD 221.1 Million in 2019 and Projected at a CAGR of 9.9%, to reach USD 354.45 Million by 2024 during the forecast period 2019 - 2024.
Nucleic Acid Labelling has many applications in fields of drug discovery and identification of new diseases. DNA and RNA are the information-carrying Nucleic acids which are of great significance for protein synthesis. They can be labelled with tags which assist in detection and purification processes. One of the labelling techniques is Nick Translation in which some of the nucleotides of a DNA sequence with their labelled analogues, creating a tagged DNA sequence which can be used as a probe in fluorescent in situ hybridization or blotting techniques. It can also be used for radiolabeling. DNA labelling has various applications in diagnosis and biotechnology.
The primary driving forces of the market are increasing funding for R&D in genomics and disease diagnosis, increasing expenditure for health care, increasing demand for personalized healthcare.
But, factors like expensive processing techniques and lack of skilled professionals are likely to hinder the growth of the market.
This research report has been segmented and sub-segmented into the following categories:
In Asia Pacific (APAC) Nucleic Acid Labelling Market, the rise in personalized medicine, and the identification of GMOs and therapeutic will drive the growth of this market areas during the forecast period. It is further anticipated that emerging markets, such as China and Brazil, will achieve significant growth by the end of the forecast period.
The Asia Pacific is attributed to the prolongation of the valence of chronic diseases such as cancer, the ageing of the population, the growing demand for targeted, personalized medicine, and aggressive government initiatives. In recent years, the government has launched initiatives that complement the growth of the APAC nucleic acid labelling market. For example, the introduction of the Precision Medicine Program in 2015 revolutionized the treatment of chronic diseases, which has accelerated the development of nucleic acid labelling and acceptance in the region. India is foreseen to be another promising area in the APAC nucleic acid labelling market.
Promising Companies dominating Asia Pacific Nucleic Acid Labelling Market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Reagents and Kits
5.1.2.1 Labels
5.1.2.1.1 Radioactive Labels
5.1.2.1.2 Non-Radioactive Labels
5.1.2.2 Probes
5.1.2.2.1 Radioactive Probes
5.1.2.2.2 Non-Radioactive Probes
5.1.3 Services
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Labelling Technique
5.2.1 Introduction
5.2.2 PCR
5.2.3 Nick Translation
5.2.4 Random Primer
5.2.5 In-Vitro Transcription
5.2.6 Reverse Transcription
5.2.7 End Labelling
5.2.8 Y-o-Y Growth Analysis, By Labelling Technique
5.2.9 Market Attractiveness Analysis, By Labelling Technique
5.2.10 Market Share Analysis, By Labelling Technique
5.3 Application
5.3.1 Introduction
5.3.2 DNA Sequencing
5.3.3 Polymerase Chain Reaction
5.3.4 Fluorescence in Situ Hybridization (FISH)
5.3.5 Microarrays
5.3.6 Blotting
5.3.7 In-Situ Hybridization
5.3.8 Other Applications
5.3.9 Y-o-Y Growth Analysis, By Application
5.3.10 Market Attractiveness Analysis, By Application
5.3.11 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Diagnostic Centres
5.4.3 Research Centres
5.4.4 Hospitals
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Labelling Technique
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Labelling Technique
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Labelling Technique
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 New England Biolabs
8.3 PerkinElmer
8.4 F.Hoffmann La-Roche AG
8.5 General Electric Company
8.6 Merck KGaA
8.7 Enzo Biochem
8.8 Promega Corporation
8.9 Vector Laboratories
8.10 Agilent Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
